Motley Fool Premium
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

GSK (LSE: GSK) Latest News

Young woman holding up three fingers
Investing Articles

Just released: our 3 top income-focused stocks to buy before February [PREMIUM PICKS]

| Mark Rogers

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

If I’d put £1,000 in GSK shares 6 months ago, here’s what I’d have now

| Dr. James Fox

What's going on with GSK shares? The pharmaceutical giant has seen its share price surge in recent months. Dr James…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

2 magnificent dividend stocks for recurrent income!

| Sumayya Mansoor

Identifying dividend stocks for passive income isn’t easy. There are many things to consider but our writer reckons she’s found…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

One overlooked value stock I’d buy today and it’s not British American Tobacco

| Harvey Jones

This FTSE 100 value stock is in need of a little love, after several years of poor performance. I think…

Read more »

GSK scientist holding lab syringe
Investing Articles

3 healthcare dividend stocks to consider for passive income in 2024

| Ben McPoland

Our writer takes a look at three dividend stocks from the US and UK that could provide attractive passive income…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

3 cheap UK shares I’d buy for passive income AND the next bull market

| Paul Summers

Some of our most established blue-chip stocks look like bargains. Paul Summers would buy now for passive income and, fingers…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

2 brilliant picks I’d love to buy in a Stocks and Shares ISA in 2024

| Harvey Jones

I'm looking for dividend and share price growth from my Stocks and Shares ISA in 2024, and these two FTSE…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

3 cheap FTSE shares to consider buying in January

| Alan Oscroft

Are we prepared for updates coming from all our favourite FTSE shares after Christmas? Here are three big names I'm…

Read more »

GSK scientist holding lab syringe
Investing Articles

At £14, the GSK share price looks like a top bargain to me

| Ben McPoland

The GSK share price looks dirt cheap at the moment. But do the risks outweigh the potential reward with this…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Investors love these FTSE 100 value shares! Here’s why I’d buy them today

| Royston Wild

Demand for these FTSE 100 shares is taking off again. I'm looking to buy them for my Stocks and Shares…

Read more »

2024 year number handwritten on a sandy beach at sunrise
Dividend Shares

3 passive income stocks investors should consider buying before 2024

| Edward Sheldon, CFA

There are some fantastic opportunities in the stock market right now for those seeking passive income, says Edward Sheldon.

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Dividend Shares

2 terrific dividend stocks in this uncertain world

| Paul Summers

The economic headlines may be improving but Paul Summers still thinks there's a place for defensive dividend stocks in his…

Read more »